Human papillomavirus vaccine - Opportunity and challenge

New England Journal of Medicine

Volumn 356, Issue 19, 2007, Pages 1990-1991

  Baden, Lindsey R ^a   Curfman, Gregory D ^a   Morrissey, Stephen ^a   Drazen, Jeffrey M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

EDITORIAL; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PRIORITY JOURNAL; PROPHYLAXIS; UTERINE CERVIX CANCER; VACCINATION;

EID: 34248341687     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078088     Document Type: Editorial

References (9)

1. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
2. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against the human papillovmavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
3. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
4. Charo RA. Politics, parents, and prophylaxis - mandating HPV vaccination in the United States. N Engl J Med 2007;356:1905-8.
5. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries - key challenges and issues. N Engl J Med 2007;356:1908-10.
6. Sawaya GF, Smith-McCune K. HPV vaccination - more answers, more questions. N Engl J Med 2007;356:1991-3.
7. Syrjanen S. Human papillovmaviruses in head and neck carcinomas. N Engl J Med 2007;356:1993-5.
8. Stewart S. Mandating HPV vaccination - private rights, public good. N Engl J Med 2007;356:1998-9.
9. Interview with R. Alta Charo. (Available at www.nejm.org.)